- Home
- FURY vs PYPD Comparison
FURY vs PYPD Comparison
Compare FURY & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FURY | PYPD |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.7M | 86.6M |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FURY | PYPD |
|---|---|---|
| Price | $0.57 | $4.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $1.70 | ★ $12.25 |
| AVG Volume (30 Days) | ★ 346.9K | 50.6K |
| Earning Date | 08-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $2.44 |
| 52 Week High | $1.02 | $5.12 |
Technical Indicators
Market Signals| Indicator | FURY | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 54.04 |
| Support Level | $0.51 | $4.08 |
| Resistance Level | $0.64 | $4.69 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 18.50 | 58.49 |
Price Performance
Historical ComparisonAbout FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.